Publications by authors named "Raymond Hohl"

Claim this Profile
S
Synergistic exacerbation of oral mucositis caused by IL-23 deficiency and oral exposure.
John T Dillon, Maura T Hickey, Jessica Saul-McBeth, Trevor Glanz, Yusuf Daboul, Raymond Hohl

mBio· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02.
Akshita Khosla, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, Raymond Hohl

Blood Transfus· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation.
Emma Zulch, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, Raymond Hohl

Leuk Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma.
Emma G Guare, Cory M Hale, Jeffrey Sivik, Erik Lehman, Yoshika Inoue, Raymond Hohl

Transpl Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis.
Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, Seema Naik, Raymond Hohl

Ann Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose total body irradiation promotes T-cells donor chimerism in reduced-intensity/non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide.
Neal Shah, Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, Raymond Hohl

Leuk Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic Effects of the Schweinfurthin Analog 5'-Methylschweinfurthin G in Malignant Plasma Cells.
Barbara Manfredi, Jeffrey D Neighbors, Raymond J Hohl

Pharmacology· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of 5'-Methylschweinfurthin G in Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma.
Emily J Koubek, Jillian S Weissenrieder, Luz E Ortiz, Nnenna Nwogu, Alexander M Pham, Raymond J Hohl

Viruses· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant.
Chenchen Zhao, Matthew Bartock, Bei Jia, Neal Shah, David F Claxton, Raymond J Hohl

J Hematol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNAseq reveals extensive metabolic disruptions in the sensitive SF-295 cell line treated with schweinfurthins.
J S Weissenrieder, J D Weissenkampen, J L Reed, M V Green, C Zheng, Raymond J Hohl

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipsychotic drugs elicit cytotoxicity in glioblastoma multiforme in a calcium-dependent, non-D receptor-dependent, manner.
Jillian S Weissenrieder, Jessie L Reed, George-Lucian Moldovan, Martin T Johnson, Mohamed Trebak, Raymond J Hohl

Pharmacol Res Perspect· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia.
Hong Zheng, Shin Mineishi, David Claxton, Junjia Zhu, Chenchen Zhao, Raymond J Hohl

Am J Hematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Dopamine D2 Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells.
Jillian S Weissenrieder, Jessie L Reed, Michelle V Green, George-Lucian Moldovan, Emily J Koubek, Raymond J Hohl

Pharmacology· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer Incidence and Aggressiveness in Appalachia versus Non-Appalachia Populations in Pennsylvania by Urban-Rural Regions, 2004-2014.
Alicia C McDonald, Emily Wasserman, Eugene J Lengerich, Jay D Raman, Nathaniel R Geyer, Raymond J Hohl

Cancer Epidemiol Biomarkers Prev· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer in Pennsylvania: The role of older age at diagnosis, aggressiveness, and environmental risk factors on treatment and mortality using data from the Pennsylvania Cancer Registry.
Shirley M Bluethmann, Ming Wang, Emily Wasserman, Chixiang Chen, Nicholas G Zaorsky, Raymond J Hohl

Cancer Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial patterns in prostate Cancer-specific mortality in Pennsylvania using Pennsylvania Cancer registry data, 2004-2014.
Ming Wang, Emily Wasserman, Nathaniel Geyer, Rachel M Carroll, Shanshan Zhao, Raymond Hohl

BMC Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML.
Chenchen Zhao, Bei Jia, Ming Wang, Todd D Schell, David F Claxton, Raymond J Hohl

Br J Haematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma.
Bryan G Allen, Kellie L Bodeker, Mark C Smith, Varun Monga, Sonia Sandhu, Raymond Hohl

Clin Cancer Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased flux through the mevalonate pathway mediates fibrotic repair without injury.
Jennifer L Larson-Casey, Mudit Vaid, Linlin Gu, Chao He, Guo-Qiang Cai, Raymond J Hohl

J Clin Invest· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer and the Dopamine D Receptor: A Pharmacological Perspective.
Jillian S Weissenrieder, Jeffrey D Neighbors, Richard B Mailman, Raymond J Hohl

J Pharmacol Exp Ther· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EomesT-bet CD8 T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia.
Bei Jia, Chenchen Zhao, Kevin L Rakszawski, David F Claxton, W Christopher Ehmann, Raymond J Hohl

Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain cholesterol metabolism and Parkinson's disease.
Xuemei Huang, Nicholas W Sterling, Guangwei Du, Dongxiao Sun, Christina Stetter, Raymond J Hohl

Mov Disord· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity.
Kathleen M Kokolus, Jeremy S Haley, Emily J Koubek, Raghavendra Gowda, Saketh S Dinavahi, Raymond J Hohl

Oncoimmunology· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Schweinfurthins: Lipid Modulators with Promising Anticancer Activity.
Emily J Koubek, Jillian S Weissenrieder, Jeffrey D Neighbors, Raymond J Hohl

Lipids· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML.
Liru Wang, Bei Jia, David F Claxton, W Christopher Ehmann, Witold B Rybka, Raymond J Hohl

Oncoimmunology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis